Request a document copy: Durable reduction in MRI disease activity with alemtuzumab in treatment-naive patients with active relapsing-remitting multiple sclerosis: 6-year follow-up of the CARE-MS I study

all files (of this document) in restricted access
the file(s) you requested
Cancel